Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo- Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa- Induced Dyskinesia in Subjects With Parkinson's Disease

NCT04912115 is registered in ClinicalTrials.gov with PharmaTher Inc. as lead sponsor.

NCT NCT04912115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04912115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo- Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa- Induced Dyskinesia in Subjects With Parkinson's Disease
Lead sponsor
PharmaTher Inc.
Phase
Phase 2
Overall status
Suspended
Start date
October 5, 2021
Completion date
March 30, 2024
Enrollment
30 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system diseases, dyskinesias, movement disorders, nervous system diseases, neurologic manifestations